Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

1998

Magi-Galluzzi C, Murphy M, Cangi MG, Loda M. Proliferation, apoptosis and cell cycle regulation in prostatic carcinogenesis. Anal Quant Cytol Histol. 1998;20(5):343-50.

Ross JM, McIntire LV, Moake JL, Kuo HJ, Qian RQ, Glanville RW, et al. Fibrillin containing elastic microfibrils support platelet adhesion under dynamic shear conditions. Thromb Haemost. 1998;79(1):155-61.

Macrì E, Loda M. Role of p27 in prostate carcinogenesis. Cancer Metastasis Rev. 1998;17(4):337-44.

Falcone DJ, Khan KM, Layne T, Fernandes L. Macrophage formation of angiostatin during inflammation. A byproduct of the activation of plasminogen. J Biol Chem. 1998;273(47):31480-5.

Magi-Galluzzi C, Montironi R, Cangi MG, Wishnow K, Loda M. Mitogen-activated protein kinases and apoptosis in PIN. Virchows Arch. 1998;432(5):407-13.

Jessup JM, Loda M. Prognostic markers in rectal carcinoma. Semin Surg Oncol. 1998;15(2):131-40.

Mahmoud NN, Boolbol SK, Dannenberg AJ, Mestre JR, Bilinski RT, Martucci C, et al. The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis. 1998;19(1):87-91.

Humar A, Jessurun J, Sharp HL, Gruessner RW. Thrombotic microangiopathy after liver-small bowel transplant. Clin Transplant. 1998;12(6):600-1.

Bao L, Loda M, Zetter BR. Thymosin beta15 expression in tumor cell lines with varying metastatic potential. Clin Exp Metastasis. 1998;16(3):227-33.

Berra E, Diaz-Meco MT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem. 1998;273(17):10792-7.